Genmab(GMAB) - 2022 Q3 - Quarterly Report

Exhibit 99.1 Genmab Announces Financial Results for the First Nine Months of 2022 November 9, 2022 Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2022 Highlights "During the first nine months of the year we continued to build on Genmab's consistent track record of success. We have strengthened our pipeline, our team and our financial foundation is even more robust. We are pleased with the recent U.S. and European regulatory submissions for epcoritamab. These submissions ar ...